Advanced stage carcinomas that have spread to distant body sites through the systemic circulation require systemic therapy. Hematological malignancies originating from the bone marrow have access to the systemic circulation from the outset and always require systemic treatment. Systemic therapies are ...
Systemic adjuvant therapy has improved the prognosis of patients with primary breast cancer. Meta-analyses have demonstrated that approximately one fourth of deaths can be avoided among younger women treated with multiple cytotoxic drug regimens and among older women treated with tamoxifen. However, with...
et al. Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: a secondary analysis of the NRG oncology RTOG 0617 Randomized Clinical Trial. J. Clin. Oncol. 35, 56–62 (2017). Article PubMed Google Scholar National Comprehensive Cancer Network...
risk patients. Everolimus is the new standard following sunitinib. High-risk parients appeared to benefit less than low-risk parients from bevacizumab plus IFN-α therapy. High-dose IL-2 has been proven effective in prolonging progression-free survival or overall survival, depending on risk group ...
High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update. Cancer J Sci Am. 2000;6(suppl 1):S11-S14.PubMedGoogle Scholar 53. Agarwala SS. Current systemic therapy for metastatic melanoma. Expert Rev Anticancer Ther. 2009;9(5):587-595.Pub...
This cohort study investigates the association between the omission of axillary dissection and systemic therapy in patients with clinically node-positive
Systemic therapy for advanced gastric cancer: a clinical practice guideline. What is the optimal chemotherapy regimen in advanced gastric cancer?Gastric cancer is the second leading cause of cancer mortality worldwide. Despite low i... Mackenzie,Spithoff,Jonker - 《Current Oncology》 被引量: 73...
Adjuvant and Neoadjuvant Immunotherapy in Non–small Cell Lung Cancer Stephen R. Broderick Pages 215-220 select article Combining Immunotherapy with Radiation Therapy in Non–Small Cell Lung Cancer Review articleAbstract only Combining Immunotherapy with Radiation Therapy in Non–Small Cell Lung Cancer ...
(4) the balance between maximizing patient-derived survival benefits versus QOL, financial and other toxicities, when compared to alternative therapy options in the patient’s overall breast cancer treatment journey. While earlier introduction of a highly efficacious drug may prolong PFS and OS to a...
Medullary Thyroid Cancer: Options for Systemic Therapy of Metastatic Disease? Medullary thyroid cancer: options for systemic therapy of metastatic disease? J Clin Oncol. 2006;24(11):1653-1655.Martins RG, Rajendran JG, Capell P, ... RG Martins,JG Rajendran,P Capell,... - 《Journal of ...